Dr. Eitan was the first to study exosomes at the National Institute on Aging (NIA). As a pioneer in the field, Dr. Eitan has developed novel methodologies and published over 27 peer reviewed articles. Prior to founding NeuroDex, Dr. Eitan served as senior scientist in a leading diagnostic company, Dr. Eitan has led research collaborations with several pharmaceutical companies, as well as academia.
Neurologist, neuroscientist, and drug developer. Executive Vice President, Head of Research and Development at Yumanity. Former VP.
Dr. Nir is a scientist, entrepreneur, and angel investor with over 28 years of experience in the commercialization of recombinant cytokines and pre-clinical contract research services. Dr. Nir is the co-founder of two preclinical Contract Research Organizations, three biotechnology companies (one publicly traded), a diagnostic company, a venture company and an incubator company, which operates 2 new bio-incubators in Natick, MA. Since 1997, Dr. Nir has served as President and CSO of SBH Sciences, where he manages all R&D and business activities.
Annastasiah Mudiwa Mhaka, PhD, consultant